$CRBG

Corebridge Financial (NYSE:CRBG) Lowered to "Strong Sell" Rating by Zacks Research

Zacks Research has downgraded Corebridge Financial (NYSE:CRBG) from a "hold" to a "strong sell" rating. This decision follows a mixed performance for the company, with its stock opening at $28.45, a market cap of $13.71 billion, and a recent earnings per share of $1.05, missing analyst estimates. Several other analysts have also adjusted their ratings and price targets for Corebridge Financial recently.

Original reporting
MarketBeat · MarketBeat
Published May 6, 2026, 10:23 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 6, 2026, 11:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Corebridge Financial (NYSE:CRBG) Lowered to "Strong Sell" Rating by Zacks Research — source image
Decision brief

The 30-second read

$CRBGBearishMed
01

Why it matters

The recent downgrade by Zacks Research may accelerate a downward trend, especially if accompanied by broader sector weakness.

02

Market read

The news is highly relevant for traders holding or considering positions in CRBG or related financial stocks, especially in the short term.

03

What to watch

Potential upcoming positive catalysts such as strategic initiatives or market corrections that could support the stock

Timing: Immediate to short-term

Background

Corebridge Financial has experienced mixed performance recently, with earnings missing estimates and multiple analyst rating adjustments.

Company-level read

Ticker impact

$CRBGBearishMedium confidence
Context

Primary focus due to recent downgrade

Expected impact

Potential 5-10% decline in short-term price

Evidence & confidence

The downgrade and earnings miss suggest deteriorating fundamentals, but technical support levels may provide some buffer.

Market effects

Potential negative sentiment spillover to insurance and financial sectors

Limited, primarily US-focused

Minimal, specific to US financial sector

Counterpoint

Some analysts may view the downgrade as an overreaction and expect a recovery based on long-term fundamentals

Key entities

  • Corebridge Financial

    A US-based insurance and financial services company.

  • Zacks Research

    An investment research firm providing stock ratings and analysis.

Related articles

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).